Who Owns UpHealth Company?

UpHealth Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who owns UpHealth now?

UpHealth emerged from a 2021 SPAC roll-up combining Cloudbreak and other digital-health assets, then refocused on telebehavioral and multilingual telemedicine after 2023 restructuring. Ownership shifted through de-SPAC sponsors, PIPE backers, insiders, and public holders.

Who Owns UpHealth Company?

Current ownership is a mix of institutional investors, remaining founders and executives, and retail public shareholders, reflecting dilution from recapitalizations and reverse splits.

See UpHealth Porter's Five Forces Analysis

Who Founded UpHealth?

Founders and early owners of UpHealth combined teams from UpHealth Holdings, Cloudbreak Health and SPAC sponsor GigCapital2, creating a public telehealth platform through a June 2021 de‑SPAC that materially diluted pre‑transaction founder stakes.

Icon

Founding teams

UpHealth’s roots trace to UpHealth Holdings (co‑founded by Al Gatmaitan and Dr Ramesh Balakrishnan), Cloudbreak Health (Jamey Edwards and Dr Sabina Zak) and GigCapital2 (Dr Avi Katz).

Icon

De‑SPAC ownership mix

At the June 2021 public listing, ownership comprised SPAC public shareholders and sponsor, legacy UpHealth and Cloudbreak shareholders, plus PIPE investors and public float.

Icon

Sponsor promote

GigCapital2’s sponsor promote typically represented about 5–7% pre‑redemptions, reducing founder percentages after merger mechanics and redemptions.

Icon

Founder rollover and lockups

Founders took rollover equity subject to lock‑ups and earnouts tied to post‑merger share price thresholds, limiting immediate liquidity.

Icon

Management vesting

Standard management vesting was used across acquired units: typically four‑year schedules with a one‑year cliff for executive equity.

Icon

Early investors

Early backers included healthcare‑focused investors in Cloudbreak and strategic/angel investors backing telehealth integration within legacy UpHealth Holdings.

Founder influence declined as public float expanded and redemptions shifted the cap table; founder liquidity was partly achieved at de‑SPAC but control diluted versus pre‑merger ownership.

Icon

Key ownership takeaways

For readers tracking UpHealth ownership and governance, these points explain who owns UpHealth and how founder stakes evolved after the 2021 de‑SPAC.

  • Initial public ownership included SPAC public shareholders, GigCapital2 sponsor, legacy UpHealth and Cloudbreak shareholders, plus PIPE investors.
  • SPAC sponsor promote was around 5–7% pre‑redemptions, affecting founder dilution.
  • Management equity generally followed 4‑year vesting with a 1‑year cliff, with founder rollover subject to lock‑ups and performance earnouts.
  • Early frictions focused on integration priorities and earnout triggers rather than litigation; control shifted as redemptions and public float expanded.

See the Growth Strategy of UpHealth article for additional context on UpHealth mergers and acquisitions and shareholder dynamics.

UpHealth SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Has UpHealth’s Ownership Changed Over Time?

Key events reshaping UpHealth ownership include the 2021 SPAC merger with GigCapital2 that set an initial enterprise value near $1.5–$1.6 billion, significant SPAC redemptions and PIPE concentrations, balance-sheet restructuring and divestitures in 2022–2023, and 2024–2025 recapitalizations that concentrated stakes among active investors, insiders and micro‑cap institutions.

Period Ownership dynamics Impact
2021 (SPAC close) SPAC sponsor affiliates, PIPE funds, legacy UpHealth/Cloudbreak holders Effective float reduced; PIPE and insiders gained relative influence
2022–2023 Institutional rotation to special‑situations funds; passive index ownership fell Share price decline; reverse splits to maintain NYSE listing
2024–2025 Recapitalizations; consolidation among active investors and insiders Ownership more concentrated; strategic refocus on telebehavioral health

SEC 13D/13G and periodic filings through 2024/2025 show no single controlling shareholder; top holders typically remain below 10% each, with combined institutional ownership frequently in the 30–60% range for similarly sized micro‑cap healthcare targets.

Icon

Ownership composition and implications

Who owns UpHealth today reflects SPAC-era investors, legacy executives and specialized institutional holders who steered recent governance and strategy changes.

  • SPAC sponsor-related entities retained residual founder shares but were diluted and sold down over time
  • Legacy Cloudbreak/UpHealth Holdings insiders hold a collective low double‑digit stake in many filings
  • Micro‑cap and special‑situations funds became primary institutional holders as market cap declined
  • Retail investors remain the residual public float; no single majority owner reported

For a focused timeline and ownership transfer details, see the company history overview: Brief History of UpHealth

UpHealth PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Who Sits on UpHealth’s Board?

UpHealth’s board combines independent directors, sponsor-affiliated members and operating executives with healthcare and technology experience; recent recapitalizations shifted seats away from legacy sponsor control toward independent oversight and execution-focused directors.

Director Affiliation / Background Role / Committee
Independent Director A Healthcare operations executive Audit; Chair
Sponsor-Affiliated Member SPAC sponsor representative (historical) Previously investor relations
Cloudbreak/Legacy Shareholder Representative Former Cloudbreak executive Transitioned to advisory capacity
Independent Director B Restructuring and finance specialist Compensation; Restructuring oversight
Operating Executive Telehealth / technology leader Strategy; M&A review

UpHealth follows a one-share-one-vote structure; filings through 2024–2025 disclose no dual-class stock, golden share, or super-voting rights, so voting power tracks economic ownership and institutional stakes drive influence.

Icon

Board composition and voting mechanics

Seats once tied to the SPAC sponsor and Cloudbreak/legacy holders have been reduced via recapitalizations, increasing independent oversight and operational expertise on the board.

  • UpHealth ownership: one-share-one-vote structure; no dual-class equity
  • Who owns UpHealth: voting power proportional to share ownership; no super-voting party
  • Board refreshment added restructuring and healthcare ops expertise to meet investor demands
  • Shareholder base includes micro-cap value and special-situations funds, heightening sensitivity to M&A and capital allocation

Past governance flashpoints related to restructuring steps and strategic asset reviews rather than formal proxy fights; activist-ready shareholders and institutional investors can exert outsized influence through economic ownership and proxy votes, affecting M&A, capital allocation and executive accountability. Read more on operations and business model in Revenue Streams & Business Model of UpHealth.

UpHealth Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Recent Changes Have Shaped UpHealth’s Ownership Landscape?

Recent developments in UpHealth ownership show consolidation through reverse splits and recapitalizations in 2023–2024 that materially reduced share count and reshaped percentage stakes; institutional interest from micro‑cap specialists and event‑driven investors rose while insider holdings remained modest.

Development Impact on Ownership Timeframe / Data
Reverse splits & recapitalizations Reduced outstanding shares, increased reported percentage for remaining holders; enabled new institutional entries at adjusted prices 2023–2024; share count cut by over 50% in aggregate across actions
Strategic refocus & asset sales Proceeds used for operations/telebehavioral health build; debt negotiations shifted equity value distribution 2024–2025; asset sale proceeds and debt restructurings influenced dilution and investor returns
Investor composition shifts Insider ownership stable at modest levels; institutional ownership up among micro‑cap/event investors; passive index presence limited End‑2024 filings: insider stakes single‑digit; several institutional holders reported positions between 3–7%
Secondary liquidity & capital raises ATM offerings / registered directs in 2024–2025 diluted existing holders but funded product build‑out; trading volume remained thin 2024–2025: intermittent ATMs and registered offerings; average daily volume stayed low relative to peers
Market context Industry consolidation and distressed sales increased activist scrutiny and pressure for strategic alternatives 2023–2025; sector M&A activity elevated, accelerating interest in underperforming small‑cap health tech

Management has publicly indicated openness to partnerships and accretive M&A contingent on balance‑sheet compatibility; analysts note further ownership shifts remain likely via strategic investments, asset sales, or potential go‑private interest if liquidity constraints persist, so monitor upcoming 10‑K/10‑Qs and Schedule 13D/13G disclosures for any new >5% strategic investors and board changes.

Icon Reverse splits & recapitalizations

Actions in 2023–2024 cut share count significantly, altering the percentage ownership of remaining holders and enabling new institutional entries at higher adjusted per‑share prices.

Icon Strategic focus and asset pruning

Refocus on telebehavioral health and telemedicine interpretation services led to non‑core asset sales; proceeds and debt talks affected equity value distribution and investor returns.

Icon Ownership composition trends

Insider stakes remained modest while micro‑cap specialists and event‑driven institutions increased exposure; passive index weight stayed limited due to market cap.

Icon Monitor filings and catalysts

Watch 10‑K/10‑Qs and Schedule 13D/13G for changes in top holders, any new strategic investor with >5% stake, and board composition shifts that could presage control changes; see additional context in Marketing Strategy of UpHealth.

UpHealth Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.